Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


CREB3L1-mediated functional and structural adaptation of the secretory pathway in hormone-stimulated thyroid cells.

García IA, Torres Demichelis V, Viale DL, Di Giusto P, Ezhova Y, Polishchuk RS, Sampieri L, Martinez H, Sztul E, Alvarez C.

J Cell Sci. 2017 Dec 15;130(24):4155-4167. doi: 10.1242/jcs.211102. Epub 2017 Nov 1.


Synthetic Tumor-Specific Promoters for Transcriptional Regulation of Viral Replication.

Lopez MV, Cafferata EG, Viale DL, Podhajcer OL.

Methods Mol Biol. 2017;1651:113-130. doi: 10.1007/978-1-4939-7223-4_9.


Improvement of bovine semen quality by removal of membrane-damaged sperm cells with DNA aptamers and magnetic nanoparticles.

Farini VL, Camaño CV, Ybarra G, Viale DL, Vichera G, Yakisich JS, Radrizzani M.

J Biotechnol. 2016 Jul 10;229:33-41. doi: 10.1016/j.jbiotec.2016.05.008. Epub 2016 May 7.


Therapeutic improvement of a stroma-targeted CRAd by incorporating motives responsive to the melanoma microenvironment.

Viale DL, Cafferata EG, Gould D, Rotondaro C, Chernajovsky Y, Curiel DT, Podhajcer OL, Veronica Lopez M.

J Invest Dermatol. 2013 Nov;133(11):2576-2584. doi: 10.1038/jid.2013.191. Epub 2013 Apr 19.


A tumor-stroma targeted oncolytic adenovirus replicated in human ovary cancer samples and inhibited growth of disseminated solid tumors in mice.

Lopez MV, Rivera AA, Viale DL, Benedetti L, Cuneo N, Kimball KJ, Wang M, Douglas JT, Zhu ZB, Bravo AI, Gidekel M, Alvarez RD, Curiel DT, Podhajcer OL.

Mol Ther. 2012 Dec;20(12):2222-33. doi: 10.1038/mt.2012.147. Epub 2012 Sep 4.


A specific subpopulation of mesenchymal stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus.

Bolontrade MF, Sganga L, Piaggio E, Viale DL, Sorrentino MA, Robinson A, Sevlever G, García MG, Mazzolini G, Podhajcer OL.

Stem Cells Dev. 2012 Sep 20;21(14):2689-702. doi: 10.1089/scd.2011.0643. Epub 2012 May 14.


Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses.

Lopez MV, Viale DL, Cafferata EG, Bravo AI, Carbone C, Gould D, Chernajovsky Y, Podhajcer OL.

PLoS One. 2009;4(4):e5119. doi: 10.1371/journal.pone.0005119. Epub 2008 Apr 8.


A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models.

Cafferata EG, Macció DR, Lopez MV, Viale DL, Carbone C, Mazzolini G, Podhajcer OL.

Clin Cancer Res. 2009 May 1;15(9):3037-49. doi: 10.1158/1078-0432.CCR-08-1161. Epub 2009 Mar 31.


Expression of a suicidal gene under control of the human secreted protein acidic and rich in cysteine (SPARC) promoter in tumor or stromal cells led to the inhibition of tumor cell growth.

Lopez MV, Blanco P, Viale DL, Cafferata EG, Carbone C, Gould D, Chernajovsky Y, Podhajcer OL.

Mol Cancer Ther. 2006 Oct;5(10):2503-11.

Supplemental Content

Loading ...
Support Center